Latest News for AHKSY
CHELMSFORD, Mass. & TOKYO--(BUSINESS WIRE)--Asahi Kasei announced it has entered into a definitive agreement to acquire all issued shares of Aicuris Anti-infective Cures AG.
TOKYO--(BUSINESS WIRE)--Asahi Kasei Pharma announced an exclusive global license agreement regarding novel lead compounds for a single target with Alchemedicine.
TOKYO--(BUSINESS WIRE)--Asahi Kasei Pharma in collaboration with Alchemedicine has announced that AK1960 has advanced to a Phase I clinical study.
DUESSELDORF, Germany--(BUSINESS WIRE)--Asahi Kasei announced the development of a new PFAS-free polyamide (PA) engineered specifically for demanding low-friction applications.
Asahi Kasei Corp. (OTCMKTS:AHKSY - Get Free Report)'s share price hit a new 52-week high during mid-day trading on Wednesday. The stock traded as high as $18.59 and last traded at $18.55, with a volume of 37773 shares. The stock had previously closed at $18.2038. Wall Street Analyst Weigh In Separately, Zacks Research upgraded
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for AHKSY.
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.